Log in to your Inderes Free account to see all free content on this page.
Vivesto
0.08 SEK
+3.45 %
Less than 1K followers
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+3.45 %
+3.70 %
-11.02 %
-28.51 %
-56.72 %
-58.22 %
-75.66 %
-97.21 %
-99.47 %
Vivesto is a pharmaceutical company focused on developing innovative treatments for serious oncology diseases. The company is researching new therapies that can improve patient outcomes and quality of life. The company operates globally with a primary presence in Europe and North America. Vivesto was founded in 1988 and is headquartered in Uppsala, Sweden.
Read moreMarket cap
93M SEK
Turnover
14.84K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7.5.
2026
General meeting '26
7.5.
2026
Interim report Q1'26
13.8.
2026
Interim report Q2'26
All
Webcasts
Press releases
3rd party
ShowingAll content types
The Board of Directors of Vivesto proposes a reverse share split and reduction of the share capital
First dogs dosed in Vivesto's PK/toxicology study with Cantrixil
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio